We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Novel Chromogenic Screening Medium Developed for MRSA

By LabMedica International staff writers
Posted on 13 Aug 2014
A novel chromogenic screening agar medium for methicillin-resistant Staphylococcus aureus (MRSA) has been developed, as rapid and definite detection of MRSA is important not only diagnosis but also for preventing the spread of this bacteria.

MRSA is known as a major nosocomial pathogen, which causes a variety of clinical symptoms including septicemia, pneumonia, and postsurgical toxic shock syndrome and treatment of infections by MRSA has been problematic since MRSA is resistant to many antimicrobial agents.

Scientists at the Kohjin Bio Co., Ltd. More...
(Saitama, Japan) compared the company’s MRSA-chrom media with other commercially available media to detect MRSA. Forty-two strains of MRSA including 41 clinical isolates from nasal cavity were inoculated into the media for the inclusivity study. For the exclusivity study, 52 gram-positive strains other than MRSA, 36 gram-negative strains, and 3 yeasts were inoculated into suitable culture media.

A total of 42 MRSA strains grew and formed typical blue- and mauve-colored colonies on MRSA-chrom and CHROMagar MRSA (CHROMagar Microbiology; Paris, France) in 24 hours. Of 42 MRSA strains, 37 strains grew and formed typical yellow colonies with egg yolk turbid reaction for S. aureus on three other media in 48 hours. All of the other microbes tested including 17 methicillin-sensitive S. aureus (MSSA) strains failed to grow on MRSA-chrom. The colonies of Bacillus cereus were spread and had a frosted glass appearance and as a result, these colonies could be distinguished from MRSA easily. When the scientists tested the 50 clinical specimens, they found that both chromogenic media detected MRSA as typical colored colony from 33 specimens after 24 hours of incubation.

The authors concluded that the novel chromogenic medium, MRSA-chrom, developed for the screening of MRSA was excellent for both selectivity and detectability. Therefore, they suggested that MRSA-chrom was a useful alternative for rapid and definitely screening of MRSA. Moreover, MRSA-chrom had a good growth for MRSA since it contained no sodium chloride. The study was published in the August 2014 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Kohjin Bio Co., Ltd.
CHROMagar Microbiology



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.